190 related articles for article (PubMed ID: 37933268)
21. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
[TBL] [Abstract][Full Text] [Related]
22. Curcumin inhibits human cancer cell growth and migration through downregulation of SVCT2.
Jang SY; Kim J; Hong E; Lee K; Na Y; Yeom CH; Park S
Cell Biochem Funct; 2023 Aug; 41(6):696-703. PubMed ID: 37322603
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells.
Akkoç Y; Berrak Ö; Arısan ED; Obakan P; Çoker-Gürkan A; Palavan-Ünsal N
Biomed Pharmacother; 2015 Apr; 71():161-71. PubMed ID: 25960232
[TBL] [Abstract][Full Text] [Related]
24. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
[TBL] [Abstract][Full Text] [Related]
25. Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.
Sun D; Zhang M; Wei M; Wang Z; Qiao W; Liu P; Zhong X; Liang Y; Chen Y; Huang Y; Yu W
Aging (Albany NY); 2022 May; 14(9):3887-3909. PubMed ID: 35507914
[TBL] [Abstract][Full Text] [Related]
26. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.
Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N
Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667
[TBL] [Abstract][Full Text] [Related]
27. Enhancing plant-derived smart nano inhibitor in targeting mammalian target of rapamycin (mTOR) in breast cancer using Curcuma longa-derived compound curcumin.
Alamri AH; Debnath S; Alqahtani T; Alqahtani A; Alshehri SA; Ghosh A
Environ Sci Pollut Res Int; 2023 Jan; ():. PubMed ID: 36719580
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
[TBL] [Abstract][Full Text] [Related]
29. Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway.
Xu X; Qin J; Liu W
Gene; 2014 Aug; 546(2):226-32. PubMed ID: 24910117
[TBL] [Abstract][Full Text] [Related]
30. Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway.
Li M; Guo T; Lin J; Huang X; Ke Q; Wu Y; Fang C; Hu C
J Ethnopharmacol; 2022 Jan; 283():114689. PubMed ID: 34592340
[TBL] [Abstract][Full Text] [Related]
31. The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway.
Zoi V; Kyritsis AP; Galani V; Lazari D; Sioka C; Voulgaris S; Alexiou GA
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672636
[TBL] [Abstract][Full Text] [Related]
32. Association of mast cell infiltration with gastric cancer progression.
Zhong B; Li Y; Liu X; Wang D
Oncol Lett; 2018 Jan; 15(1):755-764. PubMed ID: 29422964
[TBL] [Abstract][Full Text] [Related]
33. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
Liu Q; Loo WT; Sze SC; Tong Y
Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
[TBL] [Abstract][Full Text] [Related]
34. Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway.
Tian B; Zhao Y; Liang T; Ye X; Li Z; Yan D; Fu Q; Li Y
J Drug Target; 2017 Aug; 25(7):626-636. PubMed ID: 28286973
[TBL] [Abstract][Full Text] [Related]
35. Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway.
Chang M; Wu M; Li H
Am J Transl Res; 2017; 9(12):5567-5575. PubMed ID: 29312508
[TBL] [Abstract][Full Text] [Related]
36. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
37.
Qian Y; Yan Y; Lu H; Zhou T; Lv M; Fang C; Hou J; Li W; Chen X; Sun H; Li Y; Wang Z; Zhao N; Gu Y; Ding Y; Liu Y
Anticancer Agents Med Chem; 2019; 19(14):1754-1761. PubMed ID: 31364518
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of curcumin against traumatic brain injury.
Khayatan D; Razavi SM; Arab ZN; Niknejad AH; Nouri K; Momtaz S; Gumpricht E; Jamialahmadi T; Abdolghaffari AH; Barreto GE; Sahebkar A
Biomed Pharmacother; 2022 Oct; 154():113621. PubMed ID: 36055110
[TBL] [Abstract][Full Text] [Related]
39. Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment.
Ahmad I; Hoque M; Alam SSM; Zughaibi TA; Tabrez S
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047624
[TBL] [Abstract][Full Text] [Related]
40. Curcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stability.
Seo BR; Min KJ; Cho IJ; Kim SC; Kwon TK
PLoS One; 2014; 9(4):e95588. PubMed ID: 24743574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
